Hyperproteic hypocaloric enteral nutrition in the critically ill patient: A randomized controlled clinical trial.

ABSTRACT:

Introduction

Our aim was to evaluate the impact of hyperproteic hypocaloric enteral feeding on clinical outcomes in critically ill patients, particularly on severity of organic failure measured with the Sequential Organ Failure Assessment (SOFA).

Materials and methods

In a double blind clinical trial, 80 critically ill adult patients were randomized to hyperproteic hypocaloric or to isocaloric enteral nutrition; all patients completed follow-up of at least 4 days. Prescribed caloric intake was: Hyperproteic hypocaloric enteral nutrition (15 kcal/kg with 1.7 g/kg of protein) or isocaloric enteral nutrition (25 kcal/kg with 20% of the calories as protein). The main outcome was the differences in delta SOFA at 48 h. Secondary outcomes were intensive care unit (ICU) length of st

SUBMITTER: Rugeles SJ 

PROVIDER: S-EPMC3902568 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature